Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 174
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02856685 | A Study of Mitoxantrone Hydrochloride Liposome Infusion | ||
| NCT04718376 | A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer | ||
| NCT04977570 | A Study of SYHA1805 in Healthy Subjects | ||
| NCT05089461 | A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant Tumor | ||
| NCT05334810 | DP303c in Patients With HER2-positive Unresectable Locally Advanced, Relapsed, or Metastaticbreast Cancer | ||
| NCT04161430 | A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients | ||
| NCT05173545 | Clinical Pharmacokinetics of Mitoxantrone Hydrochloride Liposome Injection in Recurrent/Refractory Lymphoma Subjects | ||
| NCT02597387 | Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs | ||
| NCT02043756 | Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection | ||
| NCT03420534 | Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets | ||
| NCT05018013 | Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression | ||
| NCT04352413 | A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy | ||
| NCT06313086 | DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast Cancer | ||
| NCT03387943 | PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma | ||
| NCT04859439 | A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment | ||
| NCT05762458 | The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression | ||
| NCT05369858 | A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects | ||
| NCT03776279 | A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma | ||
| NCT03994484 | Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets | ||
| NCT05109663 | A Dose Escalation and Food Effect Study of SKLB1028 in Healthy Subjects | ||
| NCT07083505 | A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast Cancer | ||
| NCT05108545 | A Study of Amphotericin B Liposome for Injection in Patients With Persistent Neutropenia and Fever | ||
| NCT06547333 | A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT03940183 | Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes | ||
| NCT05705635 | A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer | ||
| NCT07418736 | A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT04645901 | A Study of SYHA1805 in Healthy Adult Subjects | ||
| NCT04921878 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors | ||
| NCT02059785 | Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke | ||
| NCT04983550 | Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC | ||
| NCT07623824 | A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly | ||
| NCT05146869 | A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients | ||
| NCT03419494 | Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients | ||
| NCT04931823 | Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors | ||
| NCT05072522 | A Study of SKLB1028 in Patients With Advanced Solid Tumor | ||
| NCT04364997 | Study of Desvenlafaxine in Treating Major Depressive Disorder. | ||
| NCT05761431 | A Single-dose Study of Octreotide Injection in Healthy Adult Subjects | ||
| NCT03852823 | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours | ||
| NCT06505395 | A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET) | ||
| NCT04900766 | A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma | ||
| NCT05475717 | A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKI | ||
| NCT04161547 | Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers | ||
| NCT04124484 | DBPR108 Tablets in Type 2 Diabetes Mellitus Patients | ||
| NCT06827431 | The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression | ||
| NCT04719065 | A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor | ||
| NCT05132777 | Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung Cancer | ||
| NCT05810103 | A Study of DP303c in Patients With HER2-positive Advanced Solid Tumors | ||
| NCT06947291 | Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors | ||
| NCT04509466 | Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL | ||
| NCT05715840 | Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1) |
